CellWell record HH-574858
[Effect of Cancer Antigen-125 Elimination Rate Constant K and BRCA Mutation Status on the Prognosis of Interval Debulking Surgery in Advanced High-Grade Serous Ovarian Cancer]
Yuebo Li; Mengru Li; Xiuyun Zhang; Hanjie Xu; Jie Li; Hanyuan Liu; Cheng Peng
2026
In plain language
In 106 advanced high-grade serous ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgery, a KELIM value of at least 1 was associated with higher R0 resection rates and longer progression-free survival.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-574858
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.